Cargando…
Leishmania tarentolae: an alternative approach to the production of monoclonal antibodies to treat emerging viral infections
BACKGROUND: Monoclonal antibody therapy has an important role to play as a post-exposure prophylactic and therapeutic for the treatment of viral infections, including emerging infections. For example, several patients of the present Ebola virus outbreak in West Africa were treated with ZMapp, a cock...
Autor principal: | Jones, Joshua D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506428/ https://www.ncbi.nlm.nih.gov/pubmed/26191408 http://dx.doi.org/10.1186/2049-9957-4-8 |
Ejemplares similares
-
ACRIFLAVIN RESISTANCE IN THE HEMOFLAGELLATE, LEISHMANIA TARENTOLAE
por: Strauss, Phyllis R.
Publicado: (1972) -
Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections
por: Reichert, Janice M.
Publicado: (2012) -
Crystal structure of Leishmania tarentolae hypoxanthine-guanine phosphoribosyltransferase
por: Monzani, Paulo S, et al.
Publicado: (2007) -
Decreased glutamate transport in acivicin resistant Leishmania tarentolae
por: Roy, Gaétan, et al.
Publicado: (2021) -
Potent Inhibitory Activity of Natural Product Anaephene B and Analogues against Leishmania tarentolae In Vitro
por: Zaman, Shariq M., et al.
Publicado: (2023)